Skip to search formSkip to main contentSkip to account menu

Implanon

Known as: Nourypharma brand of 3-keto-desogestrel, Organon brand of 3-keto-desogestrel 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Objective. Recently, we found decreased levels of C-reactive protein (CRP) during use of the low-dosed contraceptive implant… 
2011
2011
Objectives To present a rare case of tubal ectopic pregnancy in a woman using Implanon® after a previous contralateral ectopic… 
2009
2009
This letter to the editor describes a case of a 40-year-old patient with a localized area of lipoatrophy at the insertion site of… 
2008
2008
Abstract Our study has shown that ultrasound-guided localisation and removal of Implanon™ rods is safe, practical and highly… 
Review
2008
Review
2008
I write concerning the successful treatment of perimenopausal menorrhagia with Implanon® in a 53-year-old woman. The patient… 
Review
2006
Review
2006
This article presents a case study of the ‘oestrogen sparing effect’ of etonorgestrel especially high lighting its use in a… 
Review
2004
Review
2004
Aim The primary objective of the study was to evaluate the continuation rates of a relatively new long-acting method of… 
Review
2004
Review
2004
AIM The primary objective of the study was to evaluate the continuation rates of a relatively new long-acting method of… 
2000
2000
AbstractObjective: To examine the economic impact of a new implantable contraceptive, Implanon®, in comparison with other…